{{Rsnum
|rsid=643410
|Gene=TMEM245
|Chromosome=9
|position=109037283
|Orientation=plus
|GMAF=0.05464
|Gene_s=TMEM245
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 12.4 | 87.6
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 1.4 | 20.4 | 78.2
| ASW | 1.8 | 14.0 | 84.2
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 1.0 | 7.9 | 91.1
| LWK | 3.6 | 24.5 | 71.8
| MEX | 0.0 | 1.7 | 98.3
| MKK | 3.8 | 26.3 | 69.9
| TSI | 2.0 | 7.8 | 90.2
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382809
  |Trait=Schizophrenia (negative symptoms)
  |Title=BCL9 and C9orf5 are associated with negative symptoms in schizophrenia: meta-analysis of two genome-wide association studies.
  |RiskAllele=A
  |Pval=1E-6
  |OR=1.60
  |ORtxt=[NR]
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}